Neurocrine Biosciences, Inc. (BIT:1NBIX)
118.20
0.00 (0.00%)
Last updated: Oct 7, 2025, 9:00 AM CET
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of €11.66 billion as of October 10, 2025. Its market cap has increased by 12.46% in one year.
Market Cap
11.66B
Enterprise Value
11.24B
Revenue
2.14B
Ranking
n/a
PE Ratio
39.31
Stock Price
€118.20
Market Cap Chart
Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 167.33M to 11.66B, an increase of 6,867.00%. That is a compound annual growth rate of 15.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 11.66B | -12.67% |
Dec 31, 2024 | 13.35B | 13.98% |
Dec 29, 2023 | 11.71B | 9.01% |
Dec 30, 2022 | 10.74B | 51.23% |
Dec 31, 2021 | 7.10B | -2.95% |
Dec 31, 2020 | 7.32B | -17.01% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UniCredit | 97.20B |
Intesa Sanpaolo | 95.74B |
Enel SpA | 84.55B |
Ferrari | 61.24B |
Assicurazioni Generali | 50.22B |
Eni S.p.A. | 45.35B |
Leonardo S.p.a. | 30.49B |
Poste Italiane | 26.45B |